Moreover, inhibition of LRP8 was found to attenuate Wnt/β-catenin signalling to suppress breast cancer stem cells (BCSCs) enriched in TNBC and responsible for chemoresistance and metastasis [35, 36]. Here, LRP8 is linked to breast cancer.